Foghorn Therapeutics, Inc. (FHTX)
5.57
-0.45
(-7.48%)
USD |
NASDAQ |
Jan 20, 16:00
5.58
+0.01
(+0.18%)
After-Hours: 07:11
Foghorn Therapeutics Market Cap: 314.99M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| GT Biopharma, Inc. | 7.714M |
| Recursion Pharmaceuticals, Inc. | 2.290B |
| Erasca, Inc. | 2.783B |
| OmniAb, Inc. | 273.52M |
| CEL-SCI Corp. | 15.93M |
Market Cap Related Metrics
| PS Ratio | 13.88 |
| Price | 5.57 |
| Earnings Yield | -21.31% |